COGT
COGT
US19240Q2012
Cogent Biosciences, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
5.38B EUR
6.64B EUR
6.57B EUR
5.72B EUR
Enterprise Value
4.74B EUR
6.7B EUR
6.57B EUR
5.64B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-27.88x
--
--
--
Price to Sales
--
--
--
--
Price to Book
11.38x
12.47x
10.82x
8.99x
EV/Revenue
--
--
--
--
EV/EBITDA
-12.26x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-3.46%
-4.66%
-4.36%
-3.48%
ende